Montis Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,339
Closed -$218K 66
2023
Q1
$218K Hold
5,339
0.17% 55
2022
Q4
$274K Sell
5,339
-96
-2% -$4.6K 0.23% 46
2022
Q3
$238K Sell
5,435
-540
-9% -$26.2K 0.23% 48
2022
Q2
$313K Buy
5,975
+149
+3% +$7.59K 0.29% 41
2022
Q1
$302K Hold
5,826
0.24% 44
2021
Q4
$344K Sell
5,826
-131
-2% -$6.49K 0.25% 46
2021
Q3
$253K Sell
5,957
-1,875
-24% -$83.1K 0.22% 52
2021
Q2
$307K Buy
7,832
+235
+3% +$9.14K 0.25% 46
2021
Q1
$276K Sell
7,597
-800
-10% -$28.4K 0.26% 49
2020
Q4
$304K Buy
+8,397
New +$308K 0.3% 46

Other funds holding PFE

Montis Financial's PFE Position: Q2 2023 in Review

Montis Financial sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,339 shares — an estimated $218K sold.

Montis Financial first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $344K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Montis Financial reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Montis Financial sold 5,339 Pfizer shares in Q2 2023, an estimated $218K.
  • Montis Financial first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
  • Montis Financial's Pfizer position peaked at $344K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Montis Financial's 13F filing for Q2 2023, filed 31 Jul 2023.